Research Journal of Medical Sciences
ISSN: Online 1993-6095ISSN: Print 1815-9346
Abstract
Breast cancer is one of the most common malignancies among women globally. In recent years, the lymphocyte‐to‐monocyte ratio (LMR) has emerged as a potential biomarker for prognosis in various cancers, including breast cancer. LMR reflects the immune response, with low levels being associated with poor outcomes in malignancies. Understanding the significance of LMR in breast cancer could help in predicting prognosis and guiding treatment strategies. To assess the level of serum lymphocyte‐to‐monocyte ratio (LMR) in breast cancer patients. This study was a single center, observational, analytical, cross sectional study. It was conducted for 1 year from December 2022 to November 2023 in the Department of General surgery of Pt JNM Medical College Raipur‐Dr. Bhim Rao Ambedkar Memorial Hospital Raipur, (C.G.) located in Central India. In our study, we found that 17 out of 19 (89.5%) cases in grade 1 have more than 5.0 of L:M Ratio, 22 out of 51 (43.1%) cases in grade III have more than 5.0 of L:M Ratio.56.9% of cases in grade III have less than 5.0 of L:M Ratio. This indicates severity of Breast Cancer can be indicated by low levels of L: M Ratio. This association was found to be significant (P<0.001). Serum LMR is a potentially valuable prognostic marker in breast cancer patients. Lower LMR levels are associated with advanced disease and poor prognosis, suggesting its utility in patient stratification and management.
How to cite this article:
Amit Agrawal, Manju Singh and Rupesh Kumar Sahu. Study of Level of Serum Lymphocyte to Monocyte Ratio (LMR) in the Breast Cancer Patients.
DOI: https://doi.org/10.36478/10.36478/makrjms.2024.12.588.592
URL: https://www.makhillpublications.co/view-article/1815-9346/10.36478/makrjms.2024.12.588.592